● Recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Condition: Multiple Sclerosis · Myasthenia Gravis · Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

PhasePhase 1

Planned participants120

Who can joinAll sexes, 18 Years to 60 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple Sclerosis (RMS), Progressive Forms of Multiple Sclerosis (PMS) or Refractory Myasthenia Gravis (MG).

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (35)

Local Institution - 0011	Birmingham, Alabama, United States	Completed
University of California, Irvine	Irvine, California, United States	Recruiting
University of Colorado Anschutz Medical Campus	Aurora, Colorado, United States	Recruiting
Colorado Blood Cancer Institute	Denver, Colorado, United States	Recruiting
Yale-New Haven Hospital	North Haven, Connecticut, United States	Recruiting
University of Kansas Medical Center	Kansas City, Kansas, United States	Recruiting
Local Institution - 0039	New Orleans, Louisiana, United States	Withdrawn
Local Institution - 0005	Boston, Massachusetts, United States	Completed
Washington University School of Medicine	St Louis, Missouri, United States	Recruiting
Hackensack University Medical Center	Hackensack, New Jersey, United States	Recruiting
Icahn School of Medicine at Mount Sinai	New York, New York, United States	Recruiting
Neurological Institute of New York	New York, New York, United States	Recruiting

+ 23 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06220201